97 related articles for article (PubMed ID: 1985739)
1. A comparative study of histopathology, hormone receptors, peanut lectin binding, Ki-67 immunostaining, and nucleolar organizer region-associated proteins in human breast cancer.
Di Stefano D; Mingazzini PL; Scucchi L; Donnetti M; Marinozzi V
Cancer; 1991 Jan; 67(2):463-71. PubMed ID: 1985739
[TBL] [Abstract][Full Text] [Related]
2. Correlation between nucleolar organizer region staining and Ki-67 immunostaining in human gliomas.
Hara A; Hirayama H; Sakai N; Yamada H; Tanaka T; Mori H
Surg Neurol; 1990 May; 33(5):320-4. PubMed ID: 1691866
[TBL] [Abstract][Full Text] [Related]
3. Steroid receptor status, proliferation and metallothionein expression in primary invasive ductal breast cancers.
Surowiak P; Paluchowski P; Wysocka T; Wojnar A; Zabel M
Pathol Oncol Res; 2004; 10(4):207-11. PubMed ID: 15619641
[TBL] [Abstract][Full Text] [Related]
4. Relationship between AgNOR proteins, Ki-67 antigen, p53 immunophenotype and differentiation markers in archival breast carcinomas.
Bànkfalvi A; Schmitz K; Mock T; Kemper M; Cubick C; Böcker W
Anal Cell Pathol; 1998; 17(4):231-42. PubMed ID: 10391375
[TBL] [Abstract][Full Text] [Related]
5. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.
Barbareschi M; Leonardi E; Mauri FA; Serio G; Dalla Palma P
Am J Clin Pathol; 1992 Oct; 98(4):408-18. PubMed ID: 1357956
[TBL] [Abstract][Full Text] [Related]
6. Nucleolar organizer regions and Ki-67 immunostaining in ductal breast cancer: a comparative study.
Canepa M; Gambini C; Sementa AR; Borgiani L; Rovida S
Pathologica; 1990; 82(1078):125-32. PubMed ID: 2168032
[TBL] [Abstract][Full Text] [Related]
7. Assessment of proliferative rate of breast cancer by Ki-67 monoclonal antibody.
Marchetti E; Querzoli P; Marzola A; Bagni A; Ferretti S; Fabris G; Nenci I
Mod Pathol; 1990 Jan; 3(1):31-5. PubMed ID: 2308919
[TBL] [Abstract][Full Text] [Related]
8. A comparison of nucleolar organizer region staining and Ki-67 immunostaining in non-Hodgkin's lymphoma.
Hall PA; Crocker J; Watts A; Stansfeld AG
Histopathology; 1988 Apr; 12(4):373-81. PubMed ID: 2453436
[TBL] [Abstract][Full Text] [Related]
9. The lectin-binding sites for peanut agglutinin in invasive breast ductal carcinomas and their role as a prognostic factor.
Mustac E; Melato M; Sasso F; Valkovic T; Bottin C; Jonjic N
J Cancer Res Clin Oncol; 1996; 122(11):693-7. PubMed ID: 8898981
[TBL] [Abstract][Full Text] [Related]
10. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of progesterone receptors and the correlation with Ki-67 labeling indices in paraffin-embedded sections of meningiomas.
Nagashima G; Aoyagi M; Wakimoto H; Tamaki M; Ohno K; Hirakawa K
Neurosurgery; 1995 Sep; 37(3):478-82; discussion 483. PubMed ID: 7501113
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical determination of estrogen and progesterone receptors in breast cancer: relationship with clinicopathologic factors in 302 patients in Ivory Coast.
Effi AB; Aman NA; Koui BS; Koffi KD; Traoré ZC; Kouyate M
BMC Cancer; 2017 Feb; 17(1):115. PubMed ID: 28173783
[TBL] [Abstract][Full Text] [Related]
13. Peanut agglutinin (PNA) binding sites: a useful marker for hormonal dependence in experimental breast cancer.
Vierbuchen M; Klein PJ; Rösel S; Fischer J
Cancer Detect Prev; 1983; 6(1-2):207-14. PubMed ID: 6309384
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of estrogen and progesterone receptors performed with an antigen-retrieval technique on methacarn-fixed paraffin-embedded breast cancer tissues.
Oyaizu T; Arita S; Hatano T; Tsubura A
J Surg Res; 1996 Jan; 60(1):69-73. PubMed ID: 8592434
[TBL] [Abstract][Full Text] [Related]
15. Lectin binding sites in cultured human breast cancer cells.
Müller-Holzner E; Marth C; Kofler E; Daxenbichler G; Hofstädter F
Breast Cancer Res Treat; 1985; 5(3):277-83. PubMed ID: 2411314
[TBL] [Abstract][Full Text] [Related]
16. [A study on the relationship among estrogen receptor, progesterone receptor and glucose-6-phosphate dehydrogenase activity in primary breast cancer].
Zeng QF; Xu JH
Zhonghua Bing Li Xue Za Zhi; 1991 Jun; 20(2):107-9. PubMed ID: 1914015
[TBL] [Abstract][Full Text] [Related]
17. [Ductal carcinoma in situ: steroid receptors and proliferation kinetics].
Ronay G; Sponsel N; Tulusan AH
Pathologe; 1990 Nov; 11(6):327-31. PubMed ID: 1963219
[No Abstract] [Full Text] [Related]
18. Demonstration of estrogen and progesterone receptors as well as Ki-67 and p-145 antigens in single tumor cells from blood and pleural effusions using a slide assay.
Hirsch FW; Deibert P; Busch H; Löhr GW; Bross KJ
J Cancer Res Clin Oncol; 1991; 117(3):217-22. PubMed ID: 2033090
[TBL] [Abstract][Full Text] [Related]
19. Binding of lectins to human mammary tumors: ultrastructural study.
Calafat J; Janssen H
Breast Cancer Res Treat; 1984; 4(3):169-79. PubMed ID: 6487820
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of 1,25-dihydroxyvitamin-D3-receptors, estrogen and progesterone receptors and Ki-67 in ovarian carcinoma.
Villena-Heinsen C; Meyberg R; Axt-Fliedner R; Reitnauer K; Reichrath J; Friedrich M
Anticancer Res; 2002; 22(4):2261-7. PubMed ID: 12174912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
